January 11, 2023

IHC 0 HER2: Dr. Joe Oakley Speaks on Deep Learning-Based Assessment at SABCS 2022

Dr. Joe Oakley, Medical Director of Biomarker Development at Paige, sat down with OncologyTube to give an in-depth review our poster presented at SABCS 2022. The poster shares the findings of a study of our HER2Complete algorithm to determine if it can help pathologists uncover more details within the IHC 0 category of HER2 testing, specifically identifying what we are calling true HER2-negative cases or HER2-null. He also shared insights on the importance of HER2 testing for breast cancer diagnosis, as well as how AI can be applied for clinical oncology today.

Read the full article on Oncology Tube


Oakley, G. (2023, January 11). IHC 0 HER2: SABCS 2022 Gerard Oakley Deep Learning-Based . . . OncologyTube.